Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis

被引：22

作者：

Atallah, E. ^{[1
]}

Nussenzveig, R. ^{[1
]}

Yin, C. C. ^{[2
]}

Bueso-Ramos, C. ^{[2
]}

Tam, C. ^{[1
]}

Manshouri, T. ^{[1
]}

Pierce, S. ^{[1
]}

Kantarjian, H. ^{[1
]}

Verstovsek, S. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

来源：

LEUKEMIA | 2008年 / 22卷 / 06期

关键词：

D O I：

10.1038/sj.leu.2405054

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1295 / 1298

页数：4

共 8 条

[1] The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS) [J].

Boissinot, Marjorie ;

Garand, Richard ;

Hamidou, Mohamed ;

Hermouet, Sylvie .

BLOOD, 2006, 108 (05) :1781-1782

[2]

Jaffe E. S., 2001, PATHOLOGY GENETICS T, P58

[3] Polycythemia vera is not initiated by JAK2V17F mutation [J].

Nussenzveig, Roberto H. ;

Swierczek, Sabina I. ;

Jelinek, Jaroslav ;

Gaikwad, Amos ;

Liu, Enli ;

Verstovsek, Srdan ;

Prchal, Jaroslav F. ;

Prchal, Josef T. .

EXPERIMENTAL HEMATOLOGY, 2007, 35 (01) :32-38

[4] High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis [J].

Renneville, A. ;

Quesnel, B. ;

Charpentier, A. ;

Terriou, L. ;

Crinquette, A. ;

Lai, J-L ;

Cossement, C. ;

Lionne-Huyghe, P. ;

Rose, C. ;

Bauters, F. ;

Preudhomme, C. .

LEUKEMIA, 2006, 20 (11) :2067-2070

[5] Ringed sideroblasts with thrombocytosis: an uncommon mixed myelodysplastic/myeloproliferative disease of older adults [J].

Shaw, GR .

BRITISH JOURNAL OF HAEMATOLOGY, 2005, 131 (02) :180-184

[6]

STREETER RR, 1977, BLOOD, V50, P427

[7] Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation [J].

Szpurka, Hadrian ;

Tiu, Ramon ;

Murugesan, Gurunathan ;

Aboudola, Samer ;

Hsi, Eric D. ;

Theil, Karl S. ;

Sekeres, Mikkael A. ;

Maciejewski, Jaroslaw P. .

BLOOD, 2006, 108 (07) :2173-2181

[8] Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features [J].

Wang, S. A. ;

Hasserjian, R. P. ;

Loew, J. M. ;

Sechman, E. V. ;

Jones, D. ;

Hao, S. ;

Liu, Q. ;

Zhao, W. ;

Mehdi, M. ;

Galili, N. ;

Woda, B. ;

Raza, A. .

LEUKEMIA, 2006, 20 (09) :1641-1644

← 1 →